Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07480395

Real-World Data Collection of the GORE Devices When Used in the Treatment of Aortic Pathologies Which Requires the Incorporation of the Visceral Arteries.

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The registry population consists of patients presenting with complex aortic pathologies amenable to endovascular aortic repair that requires the incorporation of bridging stents to maintain visceral artery perfusion

Detailed description

Patients are eligible to participate in the registry if at least one BXB device is intended to be incorporated (first proximal, connected with aortic main body) to maintain visceral artery perfusion. There are no selection criteria (i.e., inclusion or exclusion criteria) based on main aortic body device used, and to allow better RWD representation of the patient population treated with different aortic component, a cap per main aortic body device has been set

Conditions

Timeline

Start date
2026-12-01
Primary completion
2031-12-01
Completion
2035-12-01
First posted
2026-03-18
Last updated
2026-03-18

Source: ClinicalTrials.gov record NCT07480395. Inclusion in this directory is not an endorsement.